Amazon Web Services (AWS) on Thursday announced Ocelot, its first-generation quantum computing chip, as it enters the race against fellow tech giants in harnessing the experimental technology.

Developed by the AWS Center for Quantum Computing at the California Institute of Technology, the new chip can reduce the costs of implementing quantum error correction by up to 90%, according to the company.

This review discusses the development and uses of imatinib mesylate, a protein tyrosine kinase inhibitor useful in the treatment of chronic myelogenous leukemia and gastrointestinal stromal tumors that was recently approved by the Food and Drug Administration. Imatinib targets platelet-derived growth factor receptor, inhibits the fusion product of the Philadelphia chromosome, and targets c-kit, a protein tyrosine kinase. The drug may also be effective in the treatment of other tumors that express platelet-derived growth factor receptor or c-kit.

From computer chips to image sensors in cameras, today’s technology is overwhelmingly based on a semiconductor called silicon. This technology has been shrinking for decades—think of early room-sized computers compared to today’s desktops—but physical limitations will soon prevent further improvement.

That’s why scientists and engineers are preparing for a new generation of technology—one based on quantum mechanics.

The electrons in so-called “quantum materials” behave differently than those in silicon, enabling more complex behaviors, like magnetism and superconductivity, that are useful for future quantum technologies.